The mismatch repair pathway functions normally at a non-AID target in germinal center B cells

Blood

Volumn 118, Issue 11, 2011, Pages 3013-3018

  Green, Blerta ^a   Belcheva, Antoaneta ^a   Nepal, Rajeev M ^a   Boulianne, Bryant ^a   Martin, Alberto ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; PROTEIN MSH2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; GENE LOCUS; GENE MUTATION; GERMINAL CENTER; MACROPHAGE; MISMATCH REPAIR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; WILD TYPE;

EID: 80052953124     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-03-345991     Document Type: Article

References (54)

1. Barnes DE, Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet. 2004;38:445-476. (Pubitemid 40013735)
2. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006;7(5):335-346.
3. Harfe BD, Jinks-Robertson S. DNA mismatch repair and genetic instability. Annu Rev Genet. 2000;34:359-399. (Pubitemid 32065926)
4. Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Carcinogenesis. 2006;27(12):2402-2408. (Pubitemid 44884097)
5. Andrew SE, Reitmair AH, Fox J, et al. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice. Oncogene. 1997;15(2):123-129. (Pubitemid 27344552)
6. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75(5):1027-1038. (Pubitemid 24014559)
7. Reitmair AH, Schmits R, Ewel A, et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet. 1995;11(1):64-70.
8. Wei K, Kucherlapati R, Edelmann W. Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med. 2002;8(7):346-353. (Pubitemid 34733389)
9. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation- induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102(5):553-563.
10. Li Z, Woo CJ, Iglesias-Ussel MD, Ronai D, Scharff MD. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 2004;18(1):1-11. (Pubitemid 38090682)
11. Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem. 2007;76:1-22.
12. Frieder D, Larijani M, Tang E, Parsa JY, Basit W, Martin A. Antibody diversification: mutational mechanisms and oncogenesis. Immunol Res. 2006;35(1-2):75-88. (Pubitemid 44547504)
13. Cascalho M, Wong J, Steinberg C, Wabl M. Mismatch repair co-opted by hypermutation. Science. 1998;279:1207-1210. (Pubitemid 28164372)
14. Kim N, Bozek G, Lo JC, Storb U. Different mismatch repair deficiencies all have the same effects on somatic hypermutation: intact primary mechanism accompanied by secondary modifications. J Exp Med. 1999;190(1):21-30. (Pubitemid 29330120)
15. Winter DB, Phung QH, Umar A, et al. Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc Natl Acad Sci U S A. 1998;95(12): 6953-6958. (Pubitemid 28278088)
16. Wiesendanger M, Kneitz B, Edelmann W, Scharff MD. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6- deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med. 2000;191(3):579-584.
17. Martin A, Li Z, Lin DP, et al. Msh2 ATPase activity is essential for somatic hypermutation at a-T basepairs and for efficient class switch recombination. J Exp Med. 2003;198(8):1171-1178. (Pubitemid 37323382)
18. Bardwell PD, Woo CJ, Wei K, et al. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nat Immunol. 2004;5(2):224-229. (Pubitemid 38208365)
19. Rada C, Ehrenstein MR, Neuberger MS, Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests 2 stages of mutational targeting. Immunity. 1998;9(1):135-141. (Pubitemid 28361302)
20. Slean MM, Panigrahi GB, Ranum LP, Pearson CE. Mutagenic roles of DNA"repair" proteins in antibody diversity and disease-associated trinucleotide repeat instability. DNARepair (Amst). 2008;7(7):1135-1154.
21. Ouchida R, Ukai A, Mori H, et al. Genetic analysis reveals an intrinsic property of the germinal center B cells to generate A:T mutations. DNA Repair (Amst). 2008;7(8):1392-1398.
22. Liu M, Duke JL, Richter DJ, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature. 2008;451(7180):841-845. (Pubitemid 351253166)
23. Peters AC, Young LC, Maeda T, Tron VA, Andrew SE. Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation. DNA Repair (Amst). 2003;2(4):427-435. (Pubitemid 36246469)
24. Nepal RM, Vesosky B, Turner J, Bryant P. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis. J Leukoc Biol. 2008;84(4):1011-1018.
25. Kohler SW, Provost GS, Fieck A, et al. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci U S A. 1991;88(18):7958-7962. (Pubitemid 21915274)
26. Nishino H, Buettner VL, Haavik J, Schaid DJ, Sommer SS. Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender, and tissue type. Environ Mol Mutagen. 1996;28(4):299-312. (Pubitemid 126450170)
27. ZaheenA, Boulianne B, Parsa JY, Ramachandran S, Gommerman JL, Martin A. AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood. 2009;114(3):547-554.
28. Peters A, Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity. 1996;4(1):57-65. (Pubitemid 26054936)
29. Fukita Y, Jacobs H, Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 1998;9(1):105-114. (Pubitemid 28361299)
30. Bachl J, Carlson C, Gray-Schopfer V, Dessing M, Olsson C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J Immunol. 2001;166(8):5051-5057. (Pubitemid 32280718)
31. Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 2003;422(6933):726-730. (Pubitemid 36514112)
32. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998; 95(20):11816-11821. (Pubitemid 28460497)
33. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998;280:1750-1752. (Pubitemid 28283498)
34. Martin A, Scharff MD. Somatic hypermutation of the AID transgene in B and non-B cells. Proc Natl Acad Sci U S A. 2002;99(19):12304-12308.
35. Wang CL, Harper RA, Wabl M. Genome-wide somatic hypermutation. Proc Natl Acad Sci U S A. 2004;101(19):7352-7356. (Pubitemid 38638036)
36. Parsa JY, Basit W, Wang CL, Gommerman JL, Carlyle JR, Martin A. AID mutates a non-immunoglobulin transgene independent of chromosomal position. Mol Immunol. 2007;44(4):567-575. (Pubitemid 44287044)
37. Yamane A, Resch W, Kuo N, et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPAin B lymphocytes. Nat Immunol. 2011;12(1):62-69.
38. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988;78(2):151-155. (Pubitemid 18069872)
39. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 1999;401(6750):301-304.
40. Krawczak M, Ball EV, Cooper DN. Neighboringnucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am J Hum Genet. 1998;63(2):474-488. (Pubitemid 30418629)
41. Zeng X, Winter DB, Kasmer C, Kraemer KH, Lehmann AR, Gearhart PJ. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol. 2001;2(6):537-541. (Pubitemid 33705856)
42. Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA. Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J Exp Med. 2005;201(8):1191-1196. (Pubitemid 40629063)
43. Delbos F, Aoufouchi S, Faili A, Weill JC, Reynaud CA. DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J Exp Med. 2007;204(1):17-23. (Pubitemid 46148751)
44. Langerak P, Nygren AO, Krijger PH, van den Berk PC, Jacobs H. A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. J Exp Med. 2007;204(8):1989-1998. (Pubitemid 47236332)
45. Wu X, Tschumper RC, Gutierrez A Jr, Mihalcik SA, Nowakowski GS, Jelinek DF. Selective induction of DNA repair pathways in human B cells activated by CD4+ T cells. PLoS One. 2010;5(12):e15549.
46. Park K, Kim J, Kim HS, Shin HS. Isolated human germinal center centroblasts have an intact mismatch repair system. J Immunol. 1998;161(11): 6128-6132. (Pubitemid 28535984)
47. Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18(1):85-98.
48. Frieder D, Larijani M, Collins C, Shulman M, Martin A. The concerted action of Msh2 and UNG stimulates somatic hypermutation at A.T base pairs. Mol Cell Biol. 2009;29(18):5148-5157.
49. Krijger PH, Langerak P, van den Berk PC, Jacobs H. Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation. J Exp Med. 2009;206(12): 2603-2611.
50. Zhou J, Ashouian N, Delepine M, et al. The origin of a developmentally regulated Igh replicon is located near the border of regulatory domains for Igh replication and expression. Proc Natl Acad Sci U S A. 2002;99(21):13693-13698. (Pubitemid 35215443)
51. Pavlov YI, Mian IM, Kunkel TA. Evidence for preferential mismatch repair of lagging strand DNA replication errors in yeast. Curr Biol. 2003;13(9): 744-748. (Pubitemid 36531021)
52. Venkatesan RN, Treuting PM, Fuller ED, et al. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol. 2007;27(21):7669-7682. (Pubitemid 350033672)
53. Ramiro AR, Jankovic M, Eisenreich T, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 2004;118(4):431-438. (Pubitemid 39485663)
54. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265-276.